Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study-Reference-Cited by-同舟云学术

Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study

Published:2014-10-16 Issue:2 Volume:35 Page:417-421
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Zeuzem Stefan¹,Dufour Jean-François²,Buti Maria³,Soriano Vicente⁴,Buynak Robert J.⁵,Mantry Parvez⁶,Taunk Jawahar⁷,Stern Jerry O.⁸,Vinisko Richard⁸,Gallivan John-Paul⁹,Böcher Wulf⁹,Mensa Federico J.⁸,

Affiliation:

1. J. W. Goethe University Hospital; Frankfurt am Main Germany

2. University Clinic for Visceral Surgery and Medicine; University of Bern; Bern Switzerland

3. Hospital Universitario Valle de Hebrón and CIBERehd del Instituto Carlos III; Barcelona Spain

4. Hospital Carlos III; Madrid Spain

5. Northwest Indiana Center for Clinical Research; Valparaiso IN USA

6. The Liver Institute at Methodist Dallas Medical Center; Dallas TX USA

7. Advance Gastroenterology Associates, LLC; Palm Harbor FL USA

8. Boehringer Ingelheim Pharmaceuticals Inc.; Ridgefield CT USA

9. Boehringer Ingelheim Pharma GmbH & Co. KG; Ingelheim Germany

Funder

Boehringer Ingelheim Pharma GmbH & Co

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12693/fullpdf

Reference15 articles.

1. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N Engl J Med,2013

2. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011

3. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011

4. Faldaprevir plus pegylated interferon alfa-2a and ribavirin in chronic HCV genotype-1 treatment-naïve patients: final results from STARTverso1, a randomised, double-blind, placebo-controlled phase III trial;Ferenci;J Hepatol,2013

5. Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial;Jacobson;Lancet,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study);Health Science Reports;2022-12-05

2. Effect of itraconazole on the pharmacokinetics of faldaprevir in healthy subjects;PHARMAZIE;2021

3. Evolution of HCV NS3/4a Protease Inhibitors;Topics in Medicinal Chemistry;2019

4. Evolution of efficacious pangenotypic hepatitis C virus therapies;Medicinal Research Reviews;2018-12-02

5. Hepatitis C Treatment in the Era of Direct-Acting Antiviral Agents;Hepatitis C in Developing Countries;2018